Paid Clinical Trials in Utah

Utah has 1,311 paid clinical trials enrolling now across cities including Salt Lake City, Murray and West Valley City. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 17, 2026.

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

1,311 clinical trials

↓ Download CSV

Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

for Advanced Malignant Solid Neoplasm

36 locations incl. Duarte

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05327010·Phase 2·Recruiting

Apply to this trial

EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study

for Heart Failure

15 locations incl. Los Angeles

Sponsor: Berlin Heart, Inc

Sex: All·Age: Up to 21

Code: NCT05610787·Enrolling By Invitation

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

for Pediatric Sarcoma, Refractory

22 locations incl. South Birmingham

Sponsor: Nationwide Children's Hospital

Sex: All·Age: 2 - 40

Code: NCT05634369·Phase 1, Phase 2·Recruiting

Apply to this trial

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for Hematologic Malignancy

29 locations incl. Los Angeles

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All·Age: 1 - 21

Code: NCT05476770·Phase 1·Recruiting

Apply to this trial

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

for Carcinoma, Non-small-Cell Lung

Drug: Amivantamab

26 locations incl. La Jolla

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05498428·Phase 2·Recruiting

Apply to this trial

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

for Chronic Kidney Disease

Drug: Finerenone

18 locations incl. Phoenix

Sponsor: Bayer

Sex: All·Age: 1 - 18

Code: NCT05457283·Phase 3·Recruiting

Apply to this trial

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

for Contraception

8 locations incl. San Jose

Sponsor: University of Utah

Sex: Female·Age: 16 - 35

Code: NCT05444582·Phase 4·Recruiting

Apply to this trial

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

for Bilateral Retinoblastoma

17 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 18

Code: NCT05504291·Phase 2·Recruiting

Apply to this trial

Long-term COVID and Rehabilitation

for Long-COVID

1 location in Salt Lake City

Sponsor: VA Office of Research and Development

Sex: All·Age: 50+·Accepts healthy volunteers

Code: NCT05373043·Recruiting

Apply to this trial

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

for Carcinoma, Non-Small-Cell Lung

25 locations incl. Birmingham

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT05208762·Phase 1·Recruiting

Apply to this trial

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for Multiple Myeloma

Drug: Daratumumab

67 locations incl. Gilbert

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05552222·Phase 3·Recruiting

Apply to this trial

Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth

for Suicide

5 locations incl. Los Angeles

Sponsor: University of California, Los Angeles

Sex: All·Age: 13 - 24

Code: NCT05304065·Phase 2·Recruiting

Apply to this trial

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

for Autism Spectrum Disorder

9 locations incl. Phoenix

Sponsor: Stalicla SA

Sex: All·Age: 12 - 65

Code: NCT05590715·Recruiting

Apply to this trial

M-Vizion™ Macroscopic Radiographic Study

for Revision Hip Arthroplasty

7 locations incl. Chicago

Sponsor: Medacta USA

Sex: All·Age: 21 - 80

Code: NCT05721859·Recruiting

Apply to this trial

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

for Ulcerative Colitis

22 locations incl. Irvine

Sponsor: University of California, San Diego

Sex: All·Age: 18+

Code: NCT05230173·Recruiting

Apply to this trial

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Drug: Venetoclax

45 locations incl. Phoenix

Sponsor: PedAL BCU, LLC

Sex: All·Age: 29 Days - 21

Code: NCT05183035·Phase 3·Recruiting

Apply to this trial

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

for Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection

22 locations incl. Birmingham

Sponsor: University of Calgary

Sex: All·Age: 9 Months - 21

Code: NCT05219110·Recruiting

Apply to this trial

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for Relapsed or Refractory Multiple Myeloma

Drug: Mezigdomide

56 locations incl. Los Alamitos

Sponsor: Celgene

Sex: All·Age: 18+

Code: NCT05519085·Phase 3·Recruiting

Apply to this trial

A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)

for Congenital Diaphragmatic Hernia

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: All ages

Code: NCT05201144·Phase 2·Recruiting

Apply to this trial

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

for Low Risk Myelodysplastic Syndromes

15 locations incl. Los Angeles

Sponsor: Rigel Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05308264·Phase 1, Phase 2·Recruiting

Apply to this trial

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

for Craniopharyngioma, Child

15 locations incl. Birmingham

Sponsor: Sabine Mueller, MD, PhD

Sex: All·Age: 1 - 39

Code: NCT05465174·Phase 2·Recruiting

Apply to this trial

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

for Idiopathic Pulmonary Fibrosis

86 locations incl. Birmingham

Sponsor: United Therapeutics

Sex: All·Age: 40+

Code: NCT04905693·Phase 3·Enrolling By Invitation

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

for Hypereosinophilic Syndrome

Drug: Depemokimab

11 locations incl. San Diego

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT05334368·Phase 3·Recruiting

Apply to this trial

Improving Care for Rural Patients With Solid Tumors

for Lung Cancer

14 locations incl. Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 99

Code: NCT04916990·Recruiting

Apply to this trial

Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

for Respiration, Artificial

11 locations incl. American Fork

Sponsor: Intermountain Health Care, Inc.

Sex: All·Age: 16+

Code: NCT05141396·Recruiting

Apply to this trial

Digital Care Programs for Female Pelvic Health

for Pelvic Floor Disorders

1 location in Draper

Sponsor: Sword Health, SA

Sex: Female·Age: 18 - 99·Accepts healthy volunteers

Code: NCT05513417·Enrolling By Invitation

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for Endometrial Adenocarcinoma

69 locations incl. Mobile

Sponsor: Acrivon Therapeutics

Sex: Female·Age: 18+

Code: NCT05548296·Phase 2·Recruiting

Apply to this trial

A Prospective Sub-Study of the Global Hypophosphatasia Registry

for Hypophosphatasia

12 locations incl. Hartford

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: All ages

Code: NCT05234567·Recruiting

Apply to this trial

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

for Pneumonia

14 locations incl. Phoenix

Sponsor: University of Utah

Sex: All·Age: Up to 18

Code: NCT05471908·Recruiting

Apply to this trial

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

for Dermatitis Atopic

Drug: Amlitelimab

96 locations incl. Birmingham

Sponsor: Sanofi

Sex: All·Age: 12+

Code: NCT05492578·Phase 2, Phase 3·Enrolling By Invitation

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

for Open Angle Glaucoma

15 locations incl. Newport Beach

Sponsor: Iantrek, Inc.

Sex: All·Age: 21+

Code: NCT05506423·Enrolling By Invitation

MiSight 1 Day Safety Post-Approval Study

for Myopia

47 locations incl. Gilbert

Sponsor: CooperVision, Inc.

Sex: All·Age: 8 - 12·Accepts healthy volunteers

Code: NCT05285527·Recruiting

Apply to this trial

A Study of XMT-1660 in Participants With Solid Tumors

for Triple Negative Breast Cancer

26 locations incl. Phoenix

Sponsor: Mersana Therapeutics

Sex: All·Age: 18+

Code: NCT05377996·Phase 1·Recruiting

Apply to this trial

Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain

for Sacroiliac Joint Complex

3 locations incl. Farmington

Sponsor: University of Utah

Sex: All·Age: 18 - 90

Code: NCT05409443·Phase 4·Recruiting

Apply to this trial

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for Breast Cancer

51 locations incl. Mobile

Sponsor: Greenwich LifeSciences, Inc.

Sex: All·Age: 18 - 100

Code: NCT05232916·Phase 3·Recruiting

Apply to this trial

Pediatric Dose Optimization for Seizures in Emergency Medical Services

for Seizures

20 locations incl. Tucson

Sponsor: Stanford University

Sex: All·Age: 6 Months - 13

Code: NCT05121324·Phase 3·Recruiting

Apply to this trial

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

for Cardiac Arrest, Out-Of-Hospital

50 locations incl. Birmingham

Sponsor: University of Michigan

Sex: All·Age: 2 Days - 17

Code: NCT05376267·Recruiting

Apply to this trial

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for Embryonal Rhabdomyosarcoma

165 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT05304585·Phase 3·Recruiting

Apply to this trial

The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial

for Extubation Failure

17 locations incl. Little Rock

Sponsor: University of Pennsylvania

Sex: All·Age: 0 Days - 9 Weeks

Code: NCT05446272·Recruiting

Apply to this trial

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

for Peripartum Cardiomyopathy, Postpartum

64 locations incl. Birmingham

Sponsor: Dennis M. McNamara, MD, MS

Sex: Female·Age: 18+

Code: NCT05180773·Phase 4·Recruiting

Apply to this trial